The mutation, occurring in a hematopoietic stem cell, creates an eryth
rocyte clone deficient in proteins capable of blocking complement-medi
ated lysis. The precise defect lies, however, in the biosynthesis of a
nchors to tether the proteins. Future research may explain how the clo
ne gains a growth advantage (perhaps shedding light on aplastic anemia
). Meanwhile, there remains the challenge of optimal diagnosis and man
agement.